REJURAN®

About REJURAN® — Korean PDRN Skin Regeneration Technology

REJURAN® is a South Korean regenerative skincare and aesthetic brand associated with PharmaResearch and its DOT™ PDRN/PN technology. PharmaResearch’s product information lists the REJURAN® Skin Booster formulation as containing c-PDRN, hyaluronic acid, and amino acids, intended to support skin elasticity and wrinkle improvement. [5]

The brand is built around salmon-derived DNA fragments, PDRN, and PN technologies designed to support skin repair, hydration, elasticity, and overall skin quality, positioning REJURAN® within the skin booster category rather than the volumizing filler category. Under the REJURAN® umbrella, professional injectable products and homecare products coexist, so claims must be carefully separated: injectable products are intended for professional aesthetic use in accordance with applicable local regulations, while REJURAN® skincare items such as the overnight serum, mask, eye cream, and toner are cosmetic products formulated for topical patient care. Clinics that already buy skinboosters from other polynucleotide or PDRN brands can evaluate REJURAN® as an addition to that category, given its salmon-derived PN positioning.

About the Manufacturer

REJURAN® is commonly associated with PharmaResearch, a South Korean company focused on regenerative medicine and DOT™ PDRN/PN technologies, with DOT™ described as a South Korean refining technology used to develop professional anti-aging skincare products based on hydrolyzed DNA.

The brand’s professional identity is tied to South Korea’s regenerative aesthetic sector, innovating skincare with regenerative science across both the professional injectable line and the homecare cosmetic range. Exact company name, registration, and corporate scope should be verified against the manufacturer’s official site and current IFUs before publication.

International adoption continues to grow, and reviews from the United States increasingly reference both the topical REJURAN® skincare range and practitioner experience with the injectable line. Manufacturer, distributor, and regulatory details can differ by market, so clinics should verify the exact product, label, IFU, registration status, and supplier documentation before procurement. Practices that source other Korean-made injectables alongside their regenerative protocols can also buy Korean dermal fillers from Doctor Medica’s wider catalog.

Most Popular REJURAN® Products

The REJURAN® range spans professional-use skin booster injectables and complementary homecare cosmetics. Product availability and formulations may vary by market; the following are commonly referenced across professional aesthetic and Korean skincare contexts.

REJURAN® Healer is the brand’s best-known professional treatment, commonly discussed as a PDRN- or PN-based skin booster used to improve skin quality, texture, and elasticity. [5] It is designed for licensed aesthetic practitioners rather than for direct consumer use.

REJURAN® Healing Essence is a professional or post-procedure skincare product associated with hydrolyzed DNA technology, used in skin-repair and recovery-oriented routines, particularly when a clinic wants to support visible comfort and radiance after aesthetic treatments.

REJURAN® Dual Effect Ampoule combines a PDRN base with additional actives in an ampoule format. Because formulations can vary by market, clinics should verify the exact ingredient list, packaging, and professional-use status before recommending it to patients.

REJURAN® Turnover Ampoule is a topical skincare product frequently searched by patients comparing REJURAN® cosmetics, serums, and Korean skincare routines. It should be framed as a cosmetic homecare product, not an injectable REJURAN® treatment.

REJURAN® Tone Up Booster sits within the cosmetic-facing range and is commonly discussed for brightening and tone support, positioned as a take-home adjunct to a broader skin health program where locally available.

REJURAN® Eye Cream is a topical eye-area product in the homecare range, distinct from professional periorbital injectable protocols — topical care and targeted injectable use differ in indications, depth, risk, and expected outcomes.

Across this range, the consistent principle is to separate professional-use injectables from topical homecare products and to match each option to the patient’s skin concerns, treatment plan, and local regulatory requirements.

REJURAN® Technology — PDRN and Hydrolyzed DNA Science

REJURAN® is built around PDRN, or polydeoxyribonucleotide — a purified mixture of DNA-derived deoxyribonucleotides typically obtained from salmon-family sources through controlled purification and sterilization. The biological interest in PDRN centers on its roles in tissue repair, anti-inflammatory activity, support for angiogenesis, and wound-healing pathways. A peer-reviewed pharmacology review describes PDRN as engaging adenosine A2A receptors while also supplying nucleosides and nucleotides to the cellular salvage pathway, positioning REJURAN® PDRN as a repair-oriented skin-quality treatment rather than a classic volumizing dermal filler. [1]

This is why REJURAN® treatment is generally discussed apart from hyaluronic acid fillers, calcium hydroxylapatite biostimulators, and PLLA collagen stimulators — protocols built around REJURAN® tend to prioritize skin quality, texture, elasticity, recovery support, and regenerative signaling over volume replacement or structural contouring. [1] The dual-effect ampoule combines PDRN with additional actives, while standard PDRN-focused formulations focus more directly on polynucleotide or hydrolyzed DNA activity. Clinics that buy polynucleotides often stock REJURAN® alongside other PN-based options to match formulation and viscosity to the treatment plan.

Treatment Areas and Indications

REJURAN® treatment targets facial skin rejuvenation, fine lines, uneven texture, visible dullness, reduced elasticity, and post-procedure skin recovery [3]. Professional protocols typically use multiple intradermal microinjection points, tailored to individual baseline skin quality, age, and photodamage.

When delivering these treatments, practitioners utilize a few key approaches:

• Injection vs. Microneedling: True dermal remodeling relies on direct intradermal injection. While device-assisted microneedling protocols are used to enhance topical penetration, this superficial delivery should not be framed as equivalent to injecting a REJURAN® skin booster into the dermis.
• The Periorbital Area: Targeted under-eye protocols require advanced anatomical knowledge and conservative dosing. While home cosmetic care relies on topical eye creams, a randomized split-face trial confirmed that injectable PN-based periocular rejuvenation significantly improves texture, hydration, and roughness with a favorable safety profile [2]. Practitioners should manage expectations by focusing on skin-quality correction rather than structural volume.
• Combination Therapies: Injectable PN is frequently paired with laser treatments, skin resurfacing, or mesotherapy protocols [3]. These synergistic combinations focus on accelerating post-procedure healing, reinforcing skin resilience, and refining texture rather than achieving immediate filling. Clinics that buy mesotherapy products for complementary skin-quality protocols often pair them with REJURAN® in the same treatment plan.

Administration — Injection Protocol and Aftercare

Professional administration typically relies on intradermal or superficial microinjection techniques to distribute the product evenly across the target zone while protecting facial anatomy.

Practitioners vary their delivery depending on the exact product Instructions for Use (IFU):

• Injection Formats: Delivery commonly involves papule-style microdroplets or micro-linear threading.
• Microneedling Adjuncts: Sterile, device-assisted microneedling protocols can support topical penetration and enhance surface quality, but this superficial delivery should never be marketed as an equivalent substitute for professional intradermal injections.

Clinical Timeline & Post-Treatment Expectations

Because REJURAN® relies on cellular repair rather than mechanical volume, managing patient timelines and healing expectations is key.

• Onest of Action: Initial improvements in skin hydration, radiance, and texture typically emerge over several weeks. Deeper collagen remodeling and regenerative milestones develop progressively over a few months.
• Treatment Schedules: Most protocols call for an initial treatment series followed by regular maintenance sessions, a pattern highly consistent with standard clinical practices for injectable polynucleotides [3].
• Managing Post-Injection Bumps: Superficial PDRN or PN microinjections naturally cause small, temporary skin papules or wheals. These localized bumps generally resolve within hours to a couple of days, depending on skin thickness and individual healing rates. Patients should be counseled on this downtime and instructed to report any atypical swelling, prolonged pain, or spreading redness.

Why Aesthetic Practitioners Choose REJURAN®

Practitioners choose REJURAN® because its PDRN and PN mechanism is distinct from that of traditional HA fillers and volumizing injectables. Rather than reshaping facial structure, REJURAN® is focused on skin quality, repair, hydration, and progressive improvement in texture and elasticity. Clinics that buy dermal fillers for structural correction can position REJURAN® alongside them as the skin-quality counterpart in a comprehensive protocol, rather than filler-only treatment plans. [2]

A second differentiator is the dual-track product ecosystem. Clinics can offer professional REJURAN® injection or skin booster protocols where legally permitted, and recommend REJURAN® cosmetics such as the toner, cream, serum, face mask, and eye cream for patients’ take-home routines — supporting continuity between in-clinic treatment and daily skincare while creating retail opportunities for the practice.

REJURAN® Alternatives

REJURAN® vs NUCLEOFILL™

REJURAN® and NUCLEOFILL™ both sit within the polynucleotide and skin-quality treatment category. REJURAN® is built around salmon-derived PDRN/PN regenerative positioning, while NUCLEOFILL™ centers on polynucleotide-based bio-restructuring and skin-quality improvement. Doctor Medica’s wholesale range lets clinics buy NUCLEOFILL™ for direct comparison against REJURAN® on formulation, viscosity, injection protocol, and local authorization before committing to one for a given patient profile.

REJURAN® vs SUNEKOS®

SUNEKOS® is generally positioned as an amino acid and hyaluronic acid biorevitalization treatment, while REJURAN® centers on PDRN or PN regenerative signaling — a contrast that makes the mechanism comparison fairly direct, since SUNEKOS® supports the extracellular matrix through amino acid/HA biostimulation rather than polynucleotide-based repair. Some practices stock both, and a clinic that decides to buy SUNEKOS® alongside REJURAN® can offer patients a choice between biorevitalization and PDRN-based skin-quality protocols.

REJURAN® vs JALUPRO®

JALUPRO® is an amino acid skin booster, while REJURAN® is built on PDRN or PN technology — both fall under skin-quality treatments rather than classic volume fillers, but the two differ in active technology, clinical positioning, and protocol design. For clinics weighing which line to add, Doctor Medica’s catalog makes it possible to buy JALUPRO® and REJURAN® from the same wholesale source and compare them directly against current patient demand.

REJURAN® vs PROFHILO®

PROFHILO® is based on high- and low-molecular-weight hyaluronic acid for skin remodeling and hydration, whereas REJURAN® is built on salmon-derived DNA fragments and polynucleotides. PROFHILO® is typically discussed for hydration, laxity, and bioremodeling, while REJURAN® centers on regeneration, repair, texture, and post-procedure support — a distinction worth reviewing before a clinic decides to buy PROFHILO® as a companion line to its REJURAN® protocols.

REJURAN® vs PLINEST®

REJURAN® and PLINEST® are both associated with polynucleotide or PDRN-based aesthetic treatment, and the comparison usually comes down to product concentration, viscosity, treatment area, and regulatory status rather than mechanism alone. Clinics that buy PLINEST® for face, neck, or under-eye protocols should check IFUs and local registration details against REJURAN®’s own indications before choosing between the two for a given case.

REJURAN® vs EXOJUV

EXOJUV is built on exosome-based regenerative technology, while REJURAN® relies on PDRN/PN or hydrolyzed DNA — both belong to the broader regenerative aesthetics conversation, but their active components and proposed signaling pathways differ considerably. Evidence levels and regulatory pathways still vary between the two categories, so practices that buy EXOJUV to expand a regenerative skin-quality menu should evaluate it against REJURAN® on a case-by-case basis.

Juvelook vs REJURAN®

Juvelook vs REJURAN® is a frequent comparison because both sit in skin-quality aesthetics, yet they belong to different technology classes. Juvelook is a PDLLA-based hybrid biostimulator combining poly-D,L-lactic acid with non-crosslinked hyaluronic acid, while REJURAN® is a PDRN-based regenerative skin booster; Juvelook tends to be chosen when collagen stimulation and mild structural support are priorities, whereas REJURAN® is more often selected for repair-oriented improvements in skin quality, texture, and post-procedure recovery.

Regulatory Status

REJURAN® injectables are not currently FDA-cleared for the US injectable market. FDA guidance lists approved dermal fillers and explains that approved products have undergone FDA review for specific indications, materials, and treatment areas; REJURAN® injectables are not included among those approved products. [4]

This point matters for clinics publishing US-facing content. REJURAN® may be used internationally under local regulatory frameworks, but US practitioners should not present REJURAN® injectables as FDA-approved, and regulatory status can differ between injectable products, professional topical products, cosmetics, and homecare skincare. Practitioners should verify current approval status in the market where treatment will be performed before purchase or use. [4]

Topical REJURAN® cosmetics and professional injectable REJURAN® products should also be evaluated under different regulatory categories — a skincare serum, mask, turnover cream, or tone up booster may be marketed differently from an injectable REJURAN® skin booster, and claims should remain category-appropriate.

REJURAN® Safety Profile

REJURAN® safety considerations depend on the product category. Professional-use injectables may cause temporary injection-site bumps, papules, redness, swelling, bruising, tenderness, and mild discomfort. Small papules are commonly expected with superficial PDRN or PN microinjection techniques and usually resolve within hours to a couple of days. Patients should receive aftercare instructions and guidance on when to report prolonged swelling, severe pain, signs of infection, or unusual reactions.

Contraindications and precautions may include known hypersensitivity to PDRN, PN, salmon-derived ingredients, or product excipients; active skin infection at the treatment site; active inflammatory dermatoses in the planned treatment area; and pregnancy or lactation when safety has not been established. Practitioners should screen for allergies, autoimmune history, anticoagulant use, keloid tendency, recent procedures, and unrealistic expectations before treatment.

Cosmetic REJURAN® skincare products have a different safety profile from injectables. REJURAN® cream, REJURAN® mask, REJURAN® toner, REJURAN® healing essence, and REJURAN® overnight serum should be assessed as topical skincare products, with attention to irritation, sensitivity, fragrance, preservatives, and post-procedure timing. Patients should not self-inject REJURAN® products purchased online.

Doctor Medica has supplied Korean and international aesthetic injectables to licensed practitioners since 2006, with wholesale pricing, guaranteed authenticity, and verifiable LOT numbers on every order. Practitioners looking to buy REJURAN® wholesale can browse the Doctor Medica catalog or contact representatives for availability, documentation, and practice-order support, and licensed clinics that want to buy REJURAN® skin booster products can request sourcing details before placing an order.

FAQs

What is REJURAN®?

REJURAN® is a Korean PDRN and polynucleotide skin-booster brand associated with regenerative skin-quality treatments. It includes professional-use products such as REJURAN® Healer and skin booster ampoules, as well as a complementary homecare range that includes serums, creams, masks, toners, and eye care products. [5]

What is REJURAN® PDRN?

REJURAN® PDRN refers to polydeoxyribonucleotide, a purified DNA-derived material commonly associated with salmon-derived DNA fragments. PDRN has been studied for tissue repair, wound healing, anti-inflammatory effects, and regenerative pathways, including activity linked to adenosine A2A receptors and the salvage pathway. [1]

How long does REJURAN® last?

REJURAN® results build progressively rather than appearing as immediate volumizing change. Many practitioners recommend a treatment series followed by maintenance sessions, but duration varies based on product selection, skin condition, injection technique, aftercare, and individual healing response.

When does REJURAN® take effect?

Initial skin quality changes may appear over several weeks. More visible regenerative changes may develop gradually over months as collagen remodeling, skin repair, and texture improvement progress.

How long do REJURAN® bumps last?

REJURAN® bumps, papules, or small wheals are common after superficial microinjection protocols. They typically settle within hours to a couple of days, depending on injection depth, treated area, skin thickness, and patient healing response.

Is REJURAN® FDA approved?

No. REJURAN® injectables are not currently FDA-cleared for the US injectable market, and REJURAN® is not included among the FDA’s approved dermal filler products. [4]

Juvelook vs REJURAN® — what’s the difference?

Different technology classes: Juvelook is a PDLLA-based hybrid biostimulator combining poly-D,L-lactic acid with non-crosslinked hyaluronic acid, while REJURAN® is a PDRN-based regenerative skin booster. Mechanism, indication, and clinical positioning differ.

What is the difference between REJURAN® injectables and the homecare range?

REJURAN® injectables, including REJURAN® Healer and related professional ampoules, are administered by licensed practitioners where permitted by local regulations. The homecare range, including REJURAN® cream, mask, toner, serum, tone-up booster, and eye cream, is cosmetic skincare for topical use by patients and should not be described as an injectable medical device.

Where can practitioners buy REJURAN® wholesale?

Licensed practitioners can buy REJURAN® wholesale through Doctor Medica, a wholesale source supplying Korean and international aesthetic injectables since 2006, with verifiable LOT number support and documentation for eligible professional accounts.

Citations

1. Squadrito F, Bitto A, Irrera N, et al. Pharmacological Activity and Clinical Use of PDRN. Frontiers in Pharmacology. 2017. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2017.00224/full
2. Lee YJ, Kim HT, Lee YJ, et al. Comparison of the effects of polynucleotide and hyaluronic acid fillers on periocular rejuvenation: a randomized, double-blind, split-face trial. Journal of Dermatological Treatment. 2022. https://pubmed.ncbi.nlm.nih.gov/32248707/
3. Rho NK, Han KH, Cho M, Kim HS. A survey on the cosmetic use of injectable polynucleotide: The pattern of practice among Korean Dermatologists. Journal of Cosmetic Dermatology. 2023. https://pubmed.ncbi.nlm.nih.gov/38093498/
4. S. Food and Drug Administration. FDA-Approved Dermal Fillers. FDA. Updated 11/09/2020. https://www.fda.gov/medical-devices/aesthetic-cosmetic-devices/fda-approved-dermal-fillers
5. REJURAN® Skin Booster. https://pharmaresearch.com/en/product/view.html?idx=57&curpage=1&code=4&srh_cate=1

For licensed medical professionals only. This content is for informational purposes only and does not constitute medical advice.